Funding
← Back to your selection

MPCi

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026

MPCi is the China-focused investment manager identified by its own site and by Tripo, Aureka and Excalipoint announcements.

Recorded funding activity

Tripo develops generative 3D tools. Aureka builds biological models and discovery infrastructure, while Excalipoint develops T-cell therapies. The manager remains distinct from US Matrix and independently operated regional firms.

Sources
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$100M
1 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

AI1
Biotech1

By country

China1
United States1

Rounds

2 in this selection
Tripo AI

Tripo AI builds generative 3D models and a creator workspace for consumers, developers, and enterprise teams.

~$445MSeries B
Lead
Aureka Biotechnologies

Builds biological foundation models and closed-loop infrastructure for drug discovery

$100MSeries B
Role not disclosed